Position history for ROYCE & ASSOCIATES LP's holdings in CATALYST PHARMACEUTICALS INC
ROYCE & ASSOCIATES LP holds 2.1M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $51.7M as of 2026-Q1. The position was increased (+9.4% shares). CPRX represents 0.5% of ROYCE & ASSOCIATES LP's portfolio.
Current Value
$51.7M
Current Shares
2.1M
Total Value Change
+$18.3M
Total Shares Change
-72,116
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 2.1M |
+9.4% |
| $51.7M |
| 0.5% |
| $23.92 |
45 |
| 2025-Q4 | Decreased | 1.9M | -6.1% | $44.6M | 0.5% | $23.29 | 0 |
| 2025-Q3 | Increased | 2M | +28.6% | $40.1M | 0.4% | $19.55 | 44 |
| 2025-Q2 | Decreased | 1.6M | -1.0% | $34.3M | 0.4% | $21.78 | 0 |
| 2025-Q1 | Decreased | 1.6M | -14.3% | $38.8M | 0.4% | $24.69 | 0 |
| 2024-Q4 | Decreased | 1.9M | -7.8% | $38.9M | 0.4% | $21.07 | 0 |
| 2024-Q3 | Decreased | 2M | -6.5% | $40.2M | 0.4% | $19.56 | 0 |
| 2024-Q2 | Increased | 2.2M | +3.7% | $33.5M | 0.3% | $15.49 | 36 |